Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142579 |
| CAS No | NA |
| Mol.F. | C18H30N2O5 |
| Mol.Wt. | 354.45 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142580 |
| CAS No | NA |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.30 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142581 |
| CAS No | NA |
| Mol.F. | C17H28N2O5 |
| Mol.Wt. | 340.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142582 |
| CAS No | NA |
| Mol.F. | C13H20N2O3 |
| Mol.Wt. | 252.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142583 |
| CAS No | NA |
| Mol.F. | C15H22N2O6 |
| Mol.Wt. | 326.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142584 |
| CAS No | NA |
| Mol.F. | C16H24N2O6 |
| Mol.Wt. | 340.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142585 |
| CAS No | NA |
| Mol.F. | C16H26N2O5 |
| Mol.Wt. | 326.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142586 |
| CAS No | NA |
| Mol.F. | C13H20N2O2 |
| Mol.Wt. | 268.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142587 |
| CAS No | NA |
| Mol.F. | C19H28N2O3 |
| Mol.Wt. | 332.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142588 |
| CAS No | NA |
| Mol.F. | C14H20N2O5 |
| Mol.Wt. | 296.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142589 |
| CAS No | NA |
| Mol.F. | C12H18N2O4 |
| Mol.Wt. | 254.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142590 |
| CAS No | NA |
| Mol.F. | C15H24N2O5 |
| Mol.Wt. | 312.37g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142591 |
| CAS No | NA |
| Mol.F. | C18H31N2O8P |
| Mol.Wt. | 432.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142592 |
| CAS No | NA |
| Mol.F. | C13H18N2O5 |
| Mol.Wt. | 282.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142593 |
| CAS No | NA |
| Mol.F. | C16H26N2O7 |
| Mol.Wt. | 358.39 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142594 |
| CAS No | NA |
| Mol.F. | C13H22N2O4 |
| Mol.Wt. | 270.33 g/mol |
| INV STATUS | UNDER SYNTHESIS |